- Home
- SLRN vs IMMR Comparison
SLRN vs IMMR Comparison
Compare SLRN & IMMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRN
- IMMR
- Stock Information
- Founded
- SLRN 2020
- IMMR 1993
- Country
- SLRN United States
- IMMR United States
- Employees
- SLRN N/A
- IMMR N/A
- Industry
- SLRN Biotechnology: Pharmaceutical Preparations
- IMMR Computer peripheral equipment
- Sector
- SLRN Health Care
- IMMR Technology
- Exchange
- SLRN Nasdaq
- IMMR Nasdaq
- Market Cap
- SLRN 224.6M
- IMMR 229.0M
- IPO Year
- SLRN 2023
- IMMR 1999
- Fundamental
- Price
- SLRN $2.09
- IMMR $7.62
- Analyst Decision
- SLRN Hold
- IMMR Strong Buy
- Analyst Count
- SLRN 5
- IMMR 2
- Target Price
- SLRN $9.60
- IMMR $12.25
- AVG Volume (30 Days)
- SLRN 743.1K
- IMMR 300.4K
- Earning Date
- SLRN 05-23-2025
- IMMR 05-27-2025
- Dividend Yield
- SLRN N/A
- IMMR 4.98%
- EPS Growth
- SLRN N/A
- IMMR 57.07
- EPS
- SLRN N/A
- IMMR 2.04
- Revenue
- SLRN N/A
- IMMR $163,133,000.00
- Revenue This Year
- SLRN $267.11
- IMMR $988.71
- Revenue Next Year
- SLRN N/A
- IMMR $109.72
- P/E Ratio
- SLRN N/A
- IMMR $3.73
- Revenue Growth
- SLRN N/A
- IMMR 338.21
- 52 Week Low
- SLRN $1.85
- IMMR $6.47
- 52 Week High
- SLRN $7.25
- IMMR $13.94
- Technical
- Relative Strength Index (RSI)
- SLRN 38.38
- IMMR 58.72
- Support Level
- SLRN $2.34
- IMMR $6.95
- Resistance Level
- SLRN $2.64
- IMMR $7.47
- Average True Range (ATR)
- SLRN 0.19
- IMMR 0.18
- MACD
- SLRN -0.01
- IMMR 0.06
- Stochastic Oscillator
- SLRN 6.61
- IMMR 88.17
About SLRN ACELYRIN INC.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. The clinical biopharma segment researches and develops treatments for diseases with pathology related to excess activation of the immune system. It is focused on providing patients with life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines.
About IMMR Immersion Corporation
Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.